Réaction #792221

ord-32ea866cd2fc4ed1901d0bf361cc46b7

Équation de réaction

Brc1cccnc1
3-bromopyridine
c1cnc(-c2cccc(-c3nccs3)n2)nc1
2-[6-(1,3-thiazol-2-yl)pyridin-2-yl]pyrimidine
c1cnc(-c2cccc(-c3nccs3)n2)nc1
2-[6-(1,3-Thiazol-2-yl)pyridin-2-yl]pyrimidine
O=C([O-])[O-].[Cs+].[Cs+]
cesium carbonate
c1cnc(-c2cccc(-c3ncc(-c4cccnc4)s3)n2)nc1
2-{6-[5-(Pyridin-3-yl)-1,3-thiazol-2-yl]pyridin-2-yl}pyrimidine

Conditions de réaction

Conditions détaillées
See reaction.notes.procedure_details.

Traitement

  1. 1
    AutreFor work-up, the solvent was removed under reduced pressure
  2. 2
    Autrethe residue was partitioned between ethyl acetate and water
  3. 3
    Autrethe organic phase was dried
  4. 4
    Concentrationconcentrated under reduced pressure
  5. 5
    Autrepurified by column chromatography on silica gel

Mode opératoire

Under argon, 79 mg (0.50 mmol) of 3-bromopyridine, 120 mg (0.50 mmol) of 2-[6-(1,3-thiazol-2-yl)pyridin-2-yl]pyrimidine (cf. step 1), 326 mg (1.0 mmol) of cesium carbonate and 8 mg (0.01 mmol) of [(t-Bu)2P(OH)]2PdCl2 (“POPd”) in 10 ml of N,N-dimethylformamide were stirred at 120° C. for 16 hours. For work-up, the solvent was removed under reduced pressure, the residue was partitioned between ethyl acetate and water and the organic phase was dried, concentrated under reduced pressure and purified by column chromatography on silica gel RP-18 (mobile phase: water/acetonitrile/formic acid). This gave 28 mg (18% of theory) of 2-{6-[5-(pyridin-3-yl)-1,3-thiazol-2-yl]pyridin-2-yl}pyrimidine.

Source

DOI: 10.6084/m9.figshare.5104873.v1Brevet: US09173396B2uspto-grants-2015_11